| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/18/2009 | CN100469390C Use of bromelain in preparing medicament for increasing individual IL-8 content |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/18/2009 | CN100469359C Deer blood powder capsule and preparation process thereof |
| 03/17/2009 | US7504511 e.g. N-[4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4((4-[2-(S)-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agent |
| 03/17/2009 | US7504483 α-β C4BP-type recombinant heteromultimeric proteins |
| 03/17/2009 | US7504482 Recombinant soluble Fc receptors |
| 03/17/2009 | US7504479 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
| 03/17/2009 | US7504257 Embryonic stem cells and neural progenitor cells derived therefrom |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504230 for drug screening by assessing the effect on localization of signal transduction proteins, particularly the protein kinase C (PKC) isoenzymes |
| 03/17/2009 | US7504224 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 03/17/2009 | US7504115 Shark cartilage extracts and use thereof for immunomodulation |
| 03/17/2009 | US7504101 Methods for enhancing antigen-specific immune response using antibodies that bind OX-40 |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2309159C Skin penetration enhancing components |
| 03/17/2009 | CA2262546C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 03/17/2009 | CA2194064C Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 03/17/2009 | CA2171434C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 03/13/2009 | CA2597878A1 Capsid protein and use therefore |
| 03/12/2009 | WO2009032972A1 Compositions and methods for treating immunological and inflammatory diseases and disorders |
| 03/12/2009 | WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009031627A1 Para-terphenyl compound or pharmacologically acceptable salt thereof, method for production of the same, and use of the same |
| 03/12/2009 | WO2009031230A1 Anti-cd20 monoclonal antibodies |
| 03/12/2009 | WO2009030998A1 Pyrimidine compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030996A1 Triazole compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030492A2 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 03/12/2009 | WO2009030257A1 Methods and compounds for treating diseases caused by reactive oxygen species |
| 03/12/2009 | WO2009030153A1 The roles of mirnas in the diagnosis and treatment of systemic lupus erythematosus |
| 03/12/2009 | WO2009029998A1 Retrometabolic compounds |
| 03/12/2009 | WO2008116185A3 Substituted pyrimidines as adenosine receptor antagonists |
| 03/12/2009 | WO2008014219A8 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 03/12/2009 | US20090069564 Methods and Compositions for Selectin Inhibition |
| 03/12/2009 | US20090069553 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/12/2009 | US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells |
| 03/12/2009 | US20090069434 Cystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 03/12/2009 | US20090069403 Composition and method for reducing allergen |
| 03/12/2009 | US20090069348 Use of Inhibitors of the Renin-Angiotensin System |
| 03/12/2009 | US20090069332 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
| 03/12/2009 | US20090069290 Administering formulation selected from calcium-channel blocker; a combination of a calcium-channel blocker and glutamate inhibitor; a combination of a calcium-channel blocker and hypertensive agent or mixtures |
| 03/12/2009 | US20090069236 PROCESS FOR THE PREPARATION OF HYPOALLERGENIC MAJOR BIRCH POLLEN ALLERGEN rBet v 1 |
| 03/12/2009 | US20090068737 Methods of inhibiting interleukin-17 receptor |
| 03/12/2009 | US20090068320 High bulk density compositions of beta-glucan and methods for making the same |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/12/2009 | US20090068233 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 03/12/2009 | US20090068230 Enterohemorrhagic escherichia coli vaccine |
| 03/12/2009 | US20090068225 Compositions and methods for orthopox virus vaccination |
| 03/12/2009 | US20090068224 Method to identify polypeptide toll-like receptor (tlr) ligands |
| 03/12/2009 | US20090068222 Bacterial expression vectors that successfully eliminate or attenuate the type I IFN response that is usually mounted by mammalian host cells in response to invasion by a bacterial expression vector |
| 03/12/2009 | US20090068204 Morinda citrifolia Based Formulations for Regulating T cell Immunomodulation in Neonatal Stock Animals |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068188 C-C chemokine receptor 3 proteins |
| 03/12/2009 | US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/12/2009 | US20090068184 Major histocompatibility complex polypeptide hybrid for use in prevention and/or treatment of infection, inflammatory, autoimmune and/or malignancy |
| 03/12/2009 | US20090068180 treating rheumatoid arthritis or graft-versus-host disease, comprising administering a Sphingosine-1-phosphate lyase inhibitors such as 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-ethanone oxime and at least one additional immunosuppressant and/or antiinflammatory agent |
| 03/12/2009 | US20090068155 Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| 03/12/2009 | US20090068145 Methods and Compositions Relating to Islet Cell Neogenesis |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | US20090068101 A1 Adenosine Receptor Antagonists |
| 03/12/2009 | CA2698713A1 Compositions and methods for treating immunological and inflammatory diseases and disorders |
| 03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 03/12/2009 | CA2696824A1 Compounds and compositions as kinase inhibitors |
| 03/11/2009 | EP2034015A1 Immunostimulatory oligonucleotide and pharmaceutical application thereof |
| 03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033660A1 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 03/11/2009 | EP2033659A2 Inhibitors of complement activation |
| 03/11/2009 | EP2033648A2 Sustained release drug delivery system containing codrugs |
| 03/11/2009 | EP2033514A2 Carbon Monoxide Improves Outcomes in Cell and Organ Transplants and Suppresses Apoptosis |
| 03/11/2009 | EP2033512A1 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 03/11/2009 | EP2032603A2 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 03/11/2009 | EP2032167A2 A novel target in the treatment of cytokine release syndrome |
| 03/11/2009 | EP2031986A1 Induction of tolerance to egg proteins |
| 03/11/2009 | EP1572689B1 Tetracyclic immunomodulatory compounds |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1461050B1 Oral immunostimulation of mammals, birds, and reptiles from (1-4) linked beta-d-mannuronic acid |
| 03/11/2009 | EP1429845B1 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1326586B1 New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 03/11/2009 | EP1305409B1 Renal regulatory elements and methods of use thereof |
| 03/11/2009 | EP1302476B1 Reduced fk228 and use thereof |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 03/11/2009 | CN101384699A Method of producing rough strains of bacteria and uses thereof |
| 03/11/2009 | CN101384268A Beta glycolipids as immuno-modulators |
| 03/11/2009 | CN101381414A Ovarian cancer anti-idiotype antibody and preparation of heat shock protein fusion protein and application |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101381406A Sword prawn allergen protein and preparation and application in medicine thereof |
| 03/11/2009 | CN101380461A Efficient thymosin enteric-coated tablets and thymosin for injection |
| 03/11/2009 | CN101380417A Preparation for quickly treating urticaria |
| 03/11/2009 | CN101380390A Preparation method of Pu-Er ripe tea standard extract PRC-001 and preparation method and use thereof |
| 03/11/2009 | CN101380386A Traditional Chinese medicine composition for tonifying the kidney yang |
| 03/11/2009 | CN101380340A Wall-broken glossy ganoderma spore powder antioxidation method |
| 03/11/2009 | CN101380339A Extraction method of Heidouba effective constituent |
| 03/11/2009 | CN101380335A Compound microbial preparation applied for cultivating baby pig in replacement of medicine additive |